IRIS
AQUARO, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.096
EU - Europa 2.496
AS - Asia 1.987
SA - Sud America 338
Continente sconosciuto - Info sul continente non disponibili 143
AF - Africa 41
OC - Oceania 5
Totale 24.106
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.008
SG - Singapore 850
RU - Federazione Russa 503
CN - Cina 419
SE - Svezia 334
DE - Germania 315
BR - Brasile 273
IT - Italia 263
UA - Ucraina 225
HK - Hong Kong 204
VN - Vietnam 168
IE - Irlanda 167
FR - Francia 165
GB - Regno Unito 137
FI - Finlandia 132
PL - Polonia 111
BD - Bangladesh 75
JP - Giappone 57
CA - Canada 50
KR - Corea 50
IN - India 43
BE - Belgio 41
CZ - Repubblica Ceca 35
AR - Argentina 28
NL - Olanda 22
ZA - Sudafrica 21
ID - Indonesia 19
TR - Turchia 15
IQ - Iraq 14
EC - Ecuador 12
ES - Italia 12
MY - Malesia 11
MX - Messico 10
AT - Austria 9
CO - Colombia 9
UZ - Uzbekistan 9
JM - Giamaica 7
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
LT - Lituania 6
AU - Australia 5
OM - Oman 5
PH - Filippine 5
RO - Romania 5
CI - Costa d'Avorio 4
CR - Costa Rica 4
KE - Kenya 4
SA - Arabia Saudita 4
VE - Venezuela 4
EU - Europa 3
GT - Guatemala 3
IL - Israele 3
IR - Iran 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MA - Marocco 3
NI - Nicaragua 3
NP - Nepal 3
PY - Paraguay 3
AZ - Azerbaigian 2
BB - Barbados 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GH - Ghana 2
GR - Grecia 2
HN - Honduras 2
LB - Libano 2
PA - Panama 2
PE - Perù 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
EE - Estonia 1
GI - Gibilterra 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MF - Saint Martin 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
NO - Norvegia 1
SC - Seychelles 1
SX - ???statistics.table.value.countryCode.SX??? 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 23.969
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.841
Wilmington 4.540
Houston 4.035
Ann Arbor 631
Ashburn 521
Singapore 517
Fairfield 479
Chandler 418
Dallas 293
Moscow 271
San Jose 264
Seattle 222
Jacksonville 208
Hong Kong 203
Cambridge 158
Dublin 154
Beijing 148
Council Bluffs 133
Medford 111
Santa Clara 104
Kraków 92
Helsinki 81
The Dalles 80
Dearborn 79
New York 79
Los Angeles 75
Rome 58
Lawrence 53
Tokyo 50
Ho Chi Minh City 49
Hanoi 44
Brussels 41
Buffalo 38
Mülheim 36
São Paulo 34
Denver 32
Boardman 31
Milan 30
Menlo Park 29
Munich 28
North Bergen 25
Brno 22
Chicago 22
Orem 22
Zhengzhou 22
Palo Alto 20
Guangzhou 19
San Diego 19
Atlanta 18
Phoenix 18
Lauterbourg 17
Warsaw 16
Brooklyn 15
Columbus 15
London 15
North Charleston 14
Toronto 14
Chennai 13
Jakarta 13
Montreal 13
Porto Alegre 13
Redwood City 13
Marseille 12
Olomouc 12
Kunming 11
Norwalk 11
Poplar 11
San Mateo 11
Shanghai 11
Verona 11
Washington 11
Amsterdam 10
Johannesburg 10
Detroit 9
Haiphong 9
Mountain View 9
Stockholm 9
Bengaluru 8
Hefei 8
Miami 8
Nuremberg 8
Redondo Beach 8
San Francisco 8
West Jordan 8
Boston 7
Dong Ket 7
Frankfurt am Main 7
Jinan 7
Nanjing 7
University Park 7
Beauvais 6
Brasília 6
Kuala Lumpur 6
Lappeenranta 6
Ankara 5
Baghdad 5
Bologna 5
Changsha 5
Curitiba 5
Da Nang 5
Totale 19.977
Salva come PNG Salva come JPEG
Nome #
1,2,3-TRIAZOLE-[2',5'-BIS-O-(TERT-BUTYLDIMETHYLSILYL)-BETA-D-RIBOFURANOSYL]-3'-SPIRO-5''-(4''-AMINO-1'',2''-OXATHIOL 2'',2''-DIOXIDE) (TSAO) ANALOGS - SYNTHESIS AND ANTI-HIV-1 ACTIVITY 1.130
Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev 544
Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4(+) T lymphocytes 542
Comparative antiviral activity of integrase inhibitors in human monocyte-derived macrophages and lymphocytes 533
Therapeutic strategies towards HIV-1 infection in macrophages 529
Antifungal activity of Cardiospermum halicacabum L. (Sapindaceae) against Trichophyton rubrum occurs through molecular interaction with fungal Hsp90 519
Activity of the (R)-Enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems 513
Understanding HIV compartments and reservoirs 512
Influenza virus A (H5N1): A pandemic risk? 510
Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection 506
Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: New therapeutic strategies 500
Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro 500
HIV-1-associated dementia during HAART therapy 496
Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines 494
Effect of maraviroc on non-R5 tropic HIV-1: Refined analysis of subjects from the phase IIb study A4001029 488
Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure 483
Human immunodeficiency virus infection and acquired immunodeficiency syndrome dementia complex: Role of cells of monocyte-macrophage lineage 481
Telomerase activity, hTERT expression, and phosphorylation are downregulated in CD4(+) T lymphocytes infected with human immunodeficiency virus type 1 (HIV-1) 480
Antiviral profile of HIV inhibitors in macrophages: Implications for therapy 475
Primary macrophages infected by human immunodeficiency virus trigger CD95-mediated apoptosis of uninfected astrocytes 470
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin 469
HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro 462
Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment 458
Novel in vivo model for the study of human immunodeficiency virus type 1 transcription inhibitors: Evaluation of new 6-desfluoroquinolone derivatives 456
gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure 456
Natural polymorphisms of HIV-1 subtype-C integrase coding region in a large group of ARV-naïve infected individuals 452
Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo 447
The contribution of peroxynitrite generation in HIV replication in human primary macrophages 447
Apoptosis and telomeres shortening related to HIV-1 induced oxidative stress in an astrocytoma cell line 446
Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives 439
Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophages 437
Antiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonates 433
The contribution of oxidative stress in apoptosis of human-cultured astroglial cells induced by supernatants of HIV-1-infected macrophages 430
In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages 429
Specific VpU codon changes were significantly associated with gp120 V3 tropic signatures in HIV-1 B-subtype 428
Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors 427
Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages 427
The role of HIV infection in neurologic injury 420
Does residual virus replication during successful HAART lead to HIV-1 genetic evolution? 416
HIV infection in macrophage: role of long-lived cells and related therapeutical strategies 416
Selected nucleotide sequence of the pol gene of the monocytotropic strain HIV type 1 BaL 412
Identification of the novel KI polyomavirus in paranasal and lung tissues 406
Profound anti-HIV-1 activity of DAPTA in monocytes/macrophages and inhibition of CCR5-mediated apoptosis in neuronal cells 401
NeuroAIDS: virological aspects of HIV infection 394
CCR5/CXCR4 dual antagonism for the improvement of HIV infection therapy 376
Effects of amprenavir on HIV-1 maturation, production and infectivity following drug withdrawal in chronically-infected monocytes/macrophages 359
Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors 313
Antimicrobial properties of the medicinal plant Cardiospermum halicacabum L: New evidence and future perspectives 292
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro 279
Different patterns of HIV-1 replication in MACROPHAGES is led by co-receptor usage 247
Identification of gp120 polymorphisms in HIV-1 B subtype potentially associated with resistance to fostemsavir 234
The degree of HIV-1 amino acid variability is strictly related to different disease progression rates 200
Phosphatidylcholine Liposomes Down-Modulate CD4 Expression Reducing HIV Entry in Human Type-1 Macrophages 126
Crucial Role of Central Nervous System as a Viral Anatomical Compartment for HIV-1 Infection 117
Evaluation of Natural and Vaccine-Induced Anti-SARS-CoV-2 Immunity: A Comparative Study between Different Groups of Volunteers 114
New Therapies and Strategies to Curb HIV Infections with a Focus on Macrophages and Reservoirs 104
POTENT ANTIVIRAL ACTIVITY OF NEW GENERATION HIV-1 MATURATION INHIBITORS ON HUMAN PRIMARY CELLS 87
Mechanisms underlying of antiretroviral drugs in different cellular reservoirs with a focus on macrophages 78
Inhibition of the Protease of Human Immunodeficiency Virus Blocks Replication and Infectivity of the Virus in Chronically Infected Macrophages 67
Totale 24.106
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.758
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.758
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022563 0 0 0 52 20 75 29 28 79 91 29 160
2022/20231.060 94 87 11 163 88 211 63 63 101 4 65 110
2023/2024434 60 142 19 9 41 55 14 17 4 12 4 57
2024/20251.436 58 288 154 97 55 144 131 107 168 81 95 58
2025/20262.940 205 162 499 254 238 130 355 337 280 230 148 102
2026/2027857 117 132 457 151 0 0 0 0 0 0 0 0
Totale 24.106